$423.79 +12.80 (%) Regeneron Pharmaceuticals Inc - NASDAQ

Dec. 18, 2014 | 04:00 PM

Partner Headlines

  1. Stocks Hit By More Selling; S&P 500 Gives Up 50-Day Line

    IBD | Dec. 15, 2014 | 14:53PM EST
  2. 3 Biotech ETFs Rally On Merger News

    Benzinga | Dec. 8, 2014 | 17:43PM EST
  3. Stocks Fall To Session Lows: GoPro Gives Up More Ground

    IBD | Dec. 8, 2014 | 13:25PM EST
  4. A Look At 3 Overbought ETFs

    Benzinga | Dec. 2, 2014 | 17:34PM EST
  5. EYLEA Injection Accepted For Priority Review By FDA For Diabetic Retinopathy In Patients With Diabetic Macular Edema

    Benzinga | Dec. 1, 2014 | 07:02AM EST
  6. Weekly Insider Sells Highlight: REGN, HSP, TYC, AAPL

    GuruFocus | Nov. 30, 2014 | 14:00PM EST
  7. Alibaba Among 5 Top Stocks With Top Profit Margins

    IBD | Nov. 23, 2014 | 08:10AM EST
  8. UPDATE: Bank Of America Reiterates On Regeneron Pharmaceuticals Following Several Positive Catalysts

    Benzinga | Nov. 21, 2014 | 10:24AM EST
  9. Sanofi's Bullish Pipeline Forecast Underwhelms Street

    IBD | Nov. 20, 2014 | 11:44AM EST
  10. UPDATE: Brean Capital Reiterates On Regeneron Pharmaceuticals On Increased Confidence

    Benzinga | Nov. 20, 2014 | 09:08AM EST
  11. US Stock Futures Mostly Flat Ahead Of Housing Data

    Benzinga | Nov. 18, 2014 | 07:11AM EST
  12. Merck Drug Works: Vytorin Study Proves Successful

    IBD | Nov. 17, 2014 | 13:35PM EST
  13. Meet 5 U.S. Techs, Biotechs With Strong Fundamentals

    IBD | Nov. 13, 2014 | 08:02AM EST
  14. Asthma treatment passes trial

    IBD | Nov. 11, 2014 | 18:30PM EST
  15. Regeneron Misses Q3 Views

    IBD | Nov. 5, 2014 | 13:07PM EST
  16. Jazz Beats And Raises Views; Regeneron Misses In Q3

    IBD | Nov. 4, 2014 | 19:02PM EST
  17. Regeneron Q3 Earnings Miss As U.S. Eylea Sales Falter

    IBD | Nov. 4, 2014 | 10:51AM EST
  18. Stocks Tightly Mixed After Open; Alibaba Climbs On Q2 Results

    IBD | Nov. 4, 2014 | 10:32AM EST
  19. Morning Market Losers

    Benzinga | Nov. 4, 2014 | 09:58AM EST
  20. Benzinga's Top #PreMarket Losers

    Benzinga | Nov. 4, 2014 | 08:14AM EST
  21. Earnings Scheduled For November 4, 2014

    Benzinga | Nov. 4, 2014 | 05:31AM EST
  22. Big Cap 20: Health Care, Tech Stocks Rule The Roost

    IBD | Nov. 3, 2014 | 17:58PM EST
  23. Video: Alibaba Leads Top Earnings Reports On Tuesday

    IBD | Nov. 3, 2014 | 14:32PM EST
  24. Making Money With Charles Payne: 10/31/14

    FoxBusiness | Oct. 31, 2014 | 18:00PM EST
  25. Stocks End Week On Fine Note; LinkedIn Surges On Earnings

    IBD | Oct. 31, 2014 | 16:29PM EST
  26. Sanofi Axes CEO, Hit By Multiple Downgrades

    IBD | Oct. 29, 2014 | 12:51PM EST
  27. Four Biotechs Lead Health Care Stocks In Big Cap 20

    IBD | Oct. 27, 2014 | 19:00PM EST
  28. Amgen Q3 Earnings Beat Estimates; Guidance Mixed

    IBD | Oct. 27, 2014 | 18:56PM EST
  29. Biotechs Show Fed Chief's Not Much Of A Stock Analyst

    IBD | Oct. 22, 2014 | 17:01PM EST
  30. Biogen Leads 5 Top Biotech Stocks As Earnings Loom

    IBD | Oct. 21, 2014 | 19:56PM EST
  31. Three Big Cap Leaders Remain In Buy Range

    IBD | Oct. 20, 2014 | 18:47PM EST
  32. UPDATE: Regeneron, Sanofi Report Commencement of Phase 3 Study Of Dupilumab In Patients With AD

    Benzinga | Oct. 20, 2014 | 07:06AM EST
  33. Regeneron's Eylea Tops Rivals

    IBD | Oct. 17, 2014 | 18:45PM EST
  34. Regeneron Eye Drug Beats Rivals While Amgen Sues

    IBD | Oct. 17, 2014 | 11:27AM EST
  35. Stocks Power Higher At Open; Regeneron Vaults On Eylea Trial

    IBD | Oct. 17, 2014 | 10:58AM EST
  36. Benzinga's Volume Movers

    Benzinga | Oct. 17, 2014 | 10:45AM EST
  37. EYLEA Injection Demonstrates Significantly Greater Gains In Visual Acuity than Both Bevacizumab And Ranibizumab In NIH-Sponsored Diabetic Macular Edema Study

    Benzinga | Oct. 17, 2014 | 07:01AM EST
  38. LinkedIn, YY Among 5 Stocks With Top Fundamentals

    IBD | Oct. 16, 2014 | 08:02AM EST
  39. Apple, McKesson Among Big Caps In Trading Range

    IBD | Oct. 13, 2014 | 18:38PM EST
  40. Wall St. Expects Solid Q3 Profit Despite Global Blues

    IBD | Oct. 6, 2014 | 17:46PM EST
  41. Medical Stocks End Week On High Note, Biotechs Lead

    IBD | Oct. 4, 2014 | 08:02AM EST
  42. Alibaba Among 5 Stocks With Superior Long-Term Growth

    IBD | Oct. 1, 2014 | 19:52PM EST
  43. Stocks Move To Session Lows; Regeneron Rises On Drug Data

    IBD | Sep. 30, 2014 | 15:04PM EST
  44. Biotech Stocks Rebound On Strong Earnings, New Drugs

    IBD | Sep. 29, 2014 | 18:32PM EST
  45. Large-Cap Tech, Biotech Names Hang Tough In Shaky Market

    IBD | Sep. 29, 2014 | 18:32PM EST
  46. Acorda To Buy Civitas, Gains Parkinson's Disease Drug

    IBD | Sep. 24, 2014 | 13:27PM EST
  47. UPDATE: Morgan Stanley Reiterates On Regeneron Pharmaceuticals Inc Following DME Doc Event

    Benzinga | Sep. 18, 2014 | 10:51AM EST
  48. Stocks Erase Modest Gains; Netflix Gaps Below 50-Day Line

    IBD | Sep. 16, 2014 | 12:12PM EST
  49. Deutsche Bank Is Bullish On Gilead Sciences, Inc. And Other Biotech Stocks

    Benzinga | Sep. 16, 2014 | 08:19AM EST
  50. Stocks Show Modest Losses; Biotechs Pressured Again

    IBD | Sep. 11, 2014 | 14:46PM EST
Trading Center